PhaseBio Pharmaceuticals, Inc. (PHAS)
Revenue
$818.00K
TTM · Period ending: · USD
PHAS Revenue
Latest reported$818.00Kperiod ending
Latest reported$818.00Kperiod ending
PHAS TTM Revenue ($0.00 → $818.00K)
TTM revenue
High-resolution chart · PNG
PHAS revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 818,000 | |
| 10,948,000 | |
| 10,831,000 | |
| 10,673,000 | |
| 10,579,000 | |
| 944,000 | |
| 1,264,000 | |
| 2,028,000 | |
| 2,028,000 | |
| 2,028,000 | |
| 2,361,000 | |
| 1,854,000 | |
| 2,024,000 | |
| 1,321,000 | |
| 668,000 | |
| 411,000 | |
| 0 |